Tissue islets of langerhans transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy32

Langerhans Cells Islets of Langerhans Epidermis Insulin-Secreting Cells Skin Glucagon-Secreting Cells Cells, Cultured Pancreas Dendritic Cells T-Lymphocytes Somatostatin-Secreting Cells Dermis Transplants Hematopoietic Stem Cells Liver Antilymphocyte Serum Stem Cells Bone Marrow Cells Lymph Nodes Portal Vein Spleen Pancreatic Ducts Fetal Blood CD4-Positive T-Lymphocytes Keratinocytes Kidney Bone Marrow Cell Line CD8-Positive T-Lymphocytes Cytoplasmic Granules Antigen-Presenting Cells Lymphocytes

Organisms15

Transplantation Chimera Mice, Inbred C57BL Mice, Inbred BALB C Mice, Inbred NOD Rats, Inbred Lew Mice, Transgenic Rats, Inbred WF Mice, Knockout Mice, SCID Mice, Inbred Strains Rats, Wistar Chimera Rats, Sprague-Dawley Mice, Inbred C3H Swine

Diseases46

Histiocytosis, Langerhans-Cell Graft vs Host Disease Langerhans Cell Sarcoma Liver Failure Diabetes Mellitus, Type 1 Postoperative Complications Dermatitis, Contact Recurrence Diabetes Mellitus, Experimental Hematologic Neoplasms Cadaver Insulinoma Eosinophilic Granuloma Liver Diseases Kidney Failure, Chronic Leukemia Bronchiolitis Obliterans Disease Models, Animal Anemia, Aplastic Blood Group Incompatibility Acute Disease Cytomegalovirus Infections Brain Death End Stage Liver Disease Histiocytosis Liver Failure, Acute Multiple Myeloma Primary Graft Dysfunction Liver Cirrhosis Delayed Graft Function Leukemia, Myeloid, Acute Biliary Atresia Carcinoma, Islet Cell Infection Dermatitis, Allergic Contact Dermatitis, Photoallergic Lymphoma, Non-Hodgkin Hepatic Veno-Occlusive Disease Liver Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoproliferative Disorders Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Hematologic Diseases Skin Diseases, Viral Carcinoma, Hepatocellular

Chemicals and Drugs49

Immunosuppressive Agents Islet Amyloid Polypeptide Insulin Mannose-Binding Lectins Glucose Antigens, CD1 Tacrolimus Cyclosporine Glucagon Antigens, CD Lectins, C-Type HLA Antigens Proinsulin Busulfan Antigens, CD34 Blood Glucose Antilymphocyte Serum Antibodies, Monoclonal Mycophenolic Acid Streptozocin Antigens, Surface Myeloablative Agonists Histocompatibility Antigens Class II RNA, Messenger Cyclophosphamide Cytokines C-Peptide Organ Preservation Solutions Melphalan ABO Blood-Group System Amyloid Prednisone Dinitrofluorobenzene Isoantibodies Biological Markers Glyceraldehyde Haptens Tolbutamide Somatostatin Isoantigens HLA-DR Antigens Diazoxide Azathioprine Vidarabine Glucose Transporter Type 2 Chemokine CCL20 Cyclosporins Tumor Necrosis Factor-alpha Interleukin-1

Analytical, Diagnostic and Therapeutic Techniques and Equipment84

Islets of Langerhans Transplantation Liver Transplantation Transplantation, Homologous Kidney Transplantation Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Transplantation, Autologous Lung Transplantation Stem Cell Transplantation Transplantation Conditioning Organ Transplantation Pancreas Transplantation Transplantation Cell Transplantation Transplantation, Isogeneic Transplantation, Heterotopic Treatment Outcome Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Immunosuppression Skin Transplantation Retrospective Studies Peripheral Blood Stem Cell Transplantation Transplantation, Heterologous Fetal Tissue Transplantation Histocompatibility Testing Corneal Transplantation Mesenchymal Stem Cell Transplantation Diabetes Mellitus, Experimental Tissue Transplantation Organ Preservation Follow-Up Studies Whole-Body Irradiation Survival Analysis Survival Rate Immunohistochemistry Brain Tissue Transplantation Cell Count Donor Selection Facial Transplantation Tissue and Organ Harvesting Cell Separation Flow Cytometry Biopsy Combined Modality Therapy Risk Factors Disease Models, Animal Postoperative Period Prognosis Remission Induction Hand Transplantation Models, Animal Fatal Outcome Patient Selection Neoplasm Transplantation Disease-Free Survival Immunophenotyping Prospective Studies Lymphocyte Transfusion Cell Culture Techniques Lymphocyte Depletion Cold Ischemia Tissue Preservation Actuarial Analysis Hematopoietic Stem Cell Mobilization Reverse Transcriptase Polymerase Chain Reaction Lymphocyte Culture Test, Mixed Graft Enhancement, Immunologic Microscopy, Electron Lymphocyte Activation Glucose Tolerance Test Anastomosis, Surgical Incidence Antineoplastic Combined Chemotherapy Protocols Tissue Culture Techniques Hepatectomy Postoperative Care Polymerase Chain Reaction Salvage Therapy Kaplan-Meier Estimate Subrenal Capsule Assay Heart-Assist Devices Multivariate Analysis

Phenomena and Processes25

Graft Survival Graft Rejection Transplantation Immunology Time Factors Transplantation Tolerance Histocompatibility Cell Differentiation Cell Count Cell Movement Immune Tolerance Cell Survival Chimerism Gene Expression Graft vs Leukemia Effect Phenotype Antigen Presentation Lymphocyte Activation Cell Proliferation Apoptosis Graft vs Tumor Effect Hematopoiesis Regeneration Cell Lineage Gene Expression Regulation Graft vs Host Reaction

Disciplines and Occupations1

Immunohistochemistry

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups3

Tissue Donors Living Donors Unrelated Donors

Health Care19

Treatment Outcome Tissue and Organ Procurement Retrospective Studies Waiting Lists Follow-Up Studies Survival Analysis Survival Rate Donor Selection Risk Factors Postoperative Period Fatal Outcome Patient Selection Disease-Free Survival Prospective Studies Actuarial Analysis Incidence Postoperative Care Kaplan-Meier Estimate Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Islets of Langerhans Transplantation Langerhans Cells Islets of Langerhans Liver Transplantation Transplantation, Homologous Kidney Transplantation Histiocytosis, Langerhans-Cell Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Transplantation, Autologous Lung Transplantation Graft Survival Stem Cell Transplantation Transplantation Conditioning Organ Transplantation Graft Rejection Pancreas Transplantation Tissue Donors Transplantation Transplantation Immunology Cell Transplantation Transplantation Chimera Immunosuppressive Agents Transplantation, Isogeneic Islet Amyloid Polypeptide Transplantation, Heterotopic Insulin Graft vs Host Disease Epidermis Treatment Outcome Living Donors Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Insulin-Secreting Cells Time Factors Immunosuppression Mannose-Binding Lectins Transplantation Tolerance Langerhans Cell Sarcoma Tissue and Organ Procurement Skin Skin Transplantation Glucose Retrospective Studies Peripheral Blood Stem Cell Transplantation Transplantation, Heterologous Fetal Tissue Transplantation Histocompatibility Testing Liver Failure Mice, Inbred C57BL Diabetes Mellitus, Type 1 Corneal Transplantation Postoperative Complications Dermatitis, Contact Antigens, CD1 Glucagon-Secreting Cells Cells, Cultured Pancreas Mice, Inbred BALB C Waiting Lists Recurrence Mesenchymal Stem Cell Transplantation Diabetes Mellitus, Experimental Tacrolimus Histocompatibility Cell Differentiation Cyclosporine Hematologic Neoplasms Tissue Transplantation Cadaver Organ Preservation Follow-Up Studies Whole-Body Irradiation Glucagon Dendritic Cells T-Lymphocytes Insulinoma Survival Analysis Survival Rate Immunohistochemistry Antigens, CD Mice, Inbred NOD Brain Tissue Transplantation Lectins, C-Type Rats, Inbred Lew Cell Count Donor Selection Mice, Transgenic Eosinophilic Granuloma Facial Transplantation HLA Antigens Cell Movement Liver Diseases Somatostatin-Secreting Cells Proinsulin Dermis Busulfan Transplants Hematopoietic Stem Cells

No FAQ available that match "tissue islets of langerhans transplantation"